A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

What is the purpose of this trial?

This is a multi-center, open-label, study to evaluate the safety and efficacy of ublituximab (TG-1101) in combination with TGR-1202 for patients who have progressed on treatment arms previously enrolled in Protocol UTX-TGR-304

TG Therapeutics, Inc.

Start Date: 11/04/2016

End Date: 09/01/2019

Last Updated: 02/22/2018

Study HIC#: 1604017653